Karen Scherr

Assistant Professor in Family Medicine and Community Health

Family Medicine and Community Health, Family Medicine

2100 Erwin Rd, Marshall L. Pickens Building, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Global Scholarship

Keywords

Research
1. Selected Grants

Scholarly Works

Teaching & Mentoring

Recognition

Professional Activities
1. Clinical Summary

Embed Profile Data

Embed Profile Data

Scholarly Works - Conferences

Linking Children in Obesity Treatment with Caregivers in the Electronic Health Record

Conference OBESITY · November 2025 Link to item Cite

Parental Awareness of and Agreement With the 2023 Clinical Practice Guidelines for Pediatric Obesity

Conference OBESITY · November 2024 Link to item Cite

A Systematic Review Examining the Reach of Clinical Pediatric Obesity Treatment Interventions

Conference OBESITY · November 2024 Link to item Cite

Parent Social Media Use for Children's Healthy Eating and Physical Activity

Conference OBESITY · November 2023 Link to item Cite

Real-world practice patterns of diabetic retinopathy screening in primary care: direct ophthalmoscopy and screening exam documentation

Conference INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE · June 2021 Link to item Cite

A LINGUISTIC EXAMINATION OF INFORMATION FRAMING IN PHYSICIAN-PATIENT CONVERSATIONS

Conference MEDICAL DECISION MAKING · January 1, 2020 Link to item Cite

AGREEMENT BETWEEN UROLOGISTS AND RADIATION ONCOLOGISTS' PROSTATE CANCER TREATMENT RECOMMENDATIONS

Conference MEDICAL DECISION MAKING · January 1, 2020 Link to item Cite

Risk tolerance and attitudes toward chemotherapy: Who chooses palliative treatment when cure is possible?

Conference Journal of Clinical Oncology · May 20, 2017 10054 Background: Many patients with acute myeloid leukemia (AML) face a difficult choice about whether to receive palliative chemotherapy or high-dose, potentially-curative chemotherapy that poses a risk of early death. How peop ... Full text Cite

Who chooses palliative chemotherapy when a cure is possible? Results of a risk tolerance survey of laypersons.

Conference Journal of Clinical Oncology · October 9, 2016 35 Background: Many patients with acute myeloid leukemia (AML) face a difficult choice about whether to receive palliative chemotherapy or high-dose, potentially-curative chemotherapy that poses a risk of early death. How people ... Full text Cite